Projects
Our projects showcase microbiome research across diverse subject areas, developing innovative solutions to address challenges and make a meaningful impact on society.
Advancing the human microbiome
Unilever’s relationship with the University of Liverpool is seen as a best in class model for how the company interacts with universities worldwide.
The treatment of Cystic Fibrosis
Exploring the uses of inhaled antibiotics in the treatment of Cystic Fibrosis.
Lameness in ruminants
Unravelling the role of the foot skin microbiome in infectious lameness in ruminants.
Inflammatory Bowel Disease (IBD)
Professor Probert’s latest research is investigating whether inflammation of the gut in IBD is aligned to bacteria.
Stabilising food production
Exploring ways to reduce Salmonella and other bacteria in chickens to stabilise food production.
Improving the treatment of Sepsis
Understanding and improving the effectiveness of antibiotic treatment for the condition of Sepsis.
Microbiome and Infectious Disease (MaID) Innovation Hub
The MaID Innovation Hub will drive development and commercialisation of microbiome therapies, novel antimicrobials and diagnostics for infectious disease.